单核细胞Y染色体嵌合缺失与经导管主动脉瓣置换术后生存率降低相关
本研究在362例成功接受TAVR的晚期主动脉瓣狭窄男性患者中,采用数字PCR检测外周血细胞Y染色体嵌合缺失(LOY),并通过单细胞RNA测序解析LOY单核细胞的基因特征。结果显示LOY范围-4%至83.4%,48%患者LOY>10%,3年死亡率随LOY升高而增加,ROC分析确定LOY>17%为预测死亡率的最佳截断值,多因素分析中LOY为死亡的独立预测因子(P<0.001)。scRNAseq揭示LOY单核细胞呈现促纤维化基因特征,TGFβ相关信号表达增加而TGFβ抑制通路表达下调。
要点
- 成功TAVR的男性患者中,LOY>17%可预测3年死亡率升高。
- LOY是TAVR术后随访期死亡的独立预测因子(P<0.001)。
- LOY单核细胞显示促纤维化TGFβ信号特征,提示心脏纤维化机制。
核心结论
- 血细胞Y染色体嵌合缺失(LOY)与成功TAVR后长期生存率显著降低相关。
- LOY单核细胞的促纤维化基因特征支持心脏纤维化在LOY效应中的作用。
研究设计与样本
- 在362例接受成功TAVR的晚期主动脉瓣狭窄男性患者中评估LOY。
- 采用数字PCR靶向AMELX与AMELY基因间6bp序列差异检测LOY(Y/X比值)。
- 通过单细胞RNA测序解析缺乏Y染色体单核细胞的基因特征。
主要发现
- LOY范围-4%至83.4%,48%患者LOY>10%。
- 3年死亡率随LOY升高而增加。
- ROC曲线分析显示LOY>17%为预测死亡率的最佳截断值。
- 多因素分析中LOY为随访期死亡的独立预测因子(P<0.001)。
- scRNAseq显示LOY单核细胞TGFβ相关信号表达增加,TGFβ抑制通路表达下调。
关键数值与推荐
- LOY>17%为预测TAVR术后死亡率的最佳截断值。
- LOY>10%见于48%的晚期主动脉瓣狭窄TAVR患者。
- 多因素分析中LOY预测死亡的P值<0.001。
临床怎么用
- 对接受TAVR的男性患者,可考虑检测血细胞LOY以辅助风险分层。
- LOY>17%提示长期生存预后较差,可能需要更密切随访。
- LOY相关促纤维化机制提示未来可探索TGFβ通路作为干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Mosaic loss of Y chromosome (LOY) in blood cells is the most common acquired mutation, increases with age, and is related to cardiovascular disease. Loss of Y chromosome induces cardiac fibrosis in murine experiments mimicking the consequences of aortic valve stenosis, the prototypical age-related disease. Cardiac fibrosis is the major determinant of mortality even after transcatheter aortic valve replacement (TAVR). It was hypothesized that LOY affects long-term outcome in men undergoing TAVR. METHODS AND RESULTS: Using digital PCR in DNA of peripheral blood cells, LOY (Y/X ratio) was assessed by targeting a 6 bp sequence difference between AMELX and AMELY genes using TaqMan. The genetic signature of monocytes lacking the Y chromosome was deciphered by scRNAseq. In 362 men with advanced aortic valve stenosis undergoing successful TAVR, LOY ranged from -4% to 83.4%, and was >10% in 48% of patients. Three-year mortality increased with LOY. Receiver operating characteristic (ROC) curve analysis revealed an optimal cut-off of LOY >17% to predict mortality. In multivariate analysis, LOY remained a significant (P < 0.001) independent predictor of death during follow-up. scRNAseq disclosed a pro-fibrotic gene signature with LOY monocytes displaying increased expression of transforming growth factor (TGF) β-associated signaling, while expression of TGFβ-inhibiting pathways was down-regulated. CONCLUSION: This is the first study to demonstrate that LOY in blood cells is associated with profoundly impaired long-term survival even after successful TAVR. Mechanistically, the pro-fibrotic gene signature sensitizing the patient-derived circulating LOY monocytes for the TGFβ signaling pathways supports a prominent role of cardiac fibrosis in contributing to the effects of LOY observed in men undergoing TAVR.
引用
- Mas-Peiro S, Abplanalp WT, Rasper T, et al. Mosaic loss of Y chromosome in monocytes is associated with lower survival after transcatheter aortic valve replacement. Eur Heart J. 2023. PMID: 36932691. doi:10.1093/eurheartj/ehad093
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。